Rektumkarzinom: was ist neu in den Leitlinien?

In the current article, new clinically relevant aspects of the updated German, Austrian, and Swiss Onkopedia guideline as well as the S3 guideline for the treatment of locally advanced rectal cancer are summarized. Important aspects include (i) the use of total neoadjuvant therapies (TNT) in rectal...

Full description

Saved in:
Bibliographic Details
Main Authors: Hofheinz, Ralf-Dieter (Author) , Rödel, Claus (Author) , Germer, Christoph-Thomas (Author)
Format: Article (Journal)
Language:German
Published: 4 September 2025
In: Die Onkologie
Year: 2025, Volume: 31, Pages: 1161-1165
ISSN:2731-7234
DOI:10.1007/s00761-025-01823-z
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00761-025-01823-z
Verlag, lizenzpflichtig, Volltext: http://link.springer.com/article/10.1007/s00761-025-01823-z
Get full text
Author Notes:Ralf-Dieter Hofheinz, Claus Rödel, Christoph-Thomas Germer

MARC

LEADER 00000caa a2200000 c 4500
001 1938520122
003 DE-627
005 20260917110033.0
007 cr uuu---uuuuu
008 251016s2025 xx |||||o 00| ||ger c
024 7 |a 10.1007/s00761-025-01823-z  |2 doi 
035 |a (DE-627)1938520122 
035 |a (DE-599)KXP1938520122 
035 |a (OCoLC)1559713232 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a ger 
084 |a 33  |2 sdnb 
100 1 |a Hofheinz, Ralf-Dieter  |d 1969-  |e VerfasserIn  |0 (DE-588)121917517  |0 (DE-627)08161876X  |0 (DE-576)292991568  |4 aut 
245 1 0 |a Rektumkarzinom  |b was ist neu in den Leitlinien?  |c Ralf-Dieter Hofheinz, Claus Rödel, Christoph-Thomas Germer 
246 1 |i Englischsprachige Zusammenfassung unter dem Titel  |a Rectal cancer - what is new in the guidelines 
264 1 |c 4 September 2025 
300 |b Diagramme 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.10.2025 
520 |a In the current article, new clinically relevant aspects of the updated German, Austrian, and Swiss Onkopedia guideline as well as the S3 guideline for the treatment of locally advanced rectal cancer are summarized. Important aspects include (i) the use of total neoadjuvant therapies (TNT) in rectal cancer with high-risk characteristics, (ii) treatment with neoadjuvant chemotherapy in patients with low risk for local recurrence, (iii) immunotherapy with dostarlimab in patients with high-grade microsatellite instability/deficient mismatch repair (MSI-high/dMMR) rectal cancer, and (iv) use of organ-preservation treatment concepts. The availability of several evidence-based treatment options requires intensive discussions within the multidisciplinary team and comprehensive patient information about treatment goals, options, and risks of the various treatment approaches. 
546 |a Sprache der Zusammenfassungen: Deutsch und Englisch 
700 1 |a Rödel, Claus  |d 1966-  |e VerfasserIn  |0 (DE-588)1152978330  |0 (DE-627)101434705X  |0 (DE-576)499988248  |4 aut 
700 1 |a Germer, Christoph-Thomas  |d 1960-  |e VerfasserIn  |0 (DE-588)1038496918  |0 (DE-627)757636381  |0 (DE-576)392505274  |4 aut 
773 0 8 |i Enthalten in  |t Die Onkologie  |d Berlin : Springer Medizin, 2022  |g 31(2025), Seite 1161-1165  |h Online-Ressource  |w (DE-627)1805500619  |w (DE-600)3120761-3  |x 2731-7234  |7 nnas  |a Rektumkarzinom was ist neu in den Leitlinien? 
773 1 8 |g volume:31  |g year:2025  |g pages:1161-1165  |g extent:5  |a Rektumkarzinom was ist neu in den Leitlinien? 
856 4 0 |u https://doi.org/10.1007/s00761-025-01823-z  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext  |7 1 
856 4 0 |u http://link.springer.com/article/10.1007/s00761-025-01823-z  |x Verlag  |z lizenzpflichtig  |3 Volltext  |7 1 
951 |a AR 
992 |a 20251016 
993 |a Article 
994 |a 2025 
998 |g 121917517  |a Hofheinz, Ralf-Dieter  |m 121917517:Hofheinz, Ralf-Dieter  |d 60000  |d 61200  |e 60000PH121917517  |e 61200PH121917517  |k 0/60000/  |k 1/60000/61200/  |p 1  |x j 
999 |a KXP-PPN1938520122  |e 4788607158 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"noteIll":"Diagramme","extent":"5 S."}],"titleAlt":[{"title":"Rectal cancer - what is new in the guidelines"}],"id":{"doi":["10.1007/s00761-025-01823-z"],"eki":["1938520122"]},"name":{"displayForm":["Ralf-Dieter Hofheinz, Claus Rödel, Christoph-Thomas Germer"]},"title":[{"title_sort":"Rektumkarzinom","subtitle":"was ist neu in den Leitlinien?","title":"Rektumkarzinom"}],"relHost":[{"disp":"Rektumkarzinom was ist neu in den Leitlinien?Die Onkologie","note":["Gesehen am 01.06.22"],"recId":"1805500619","origin":[{"publisherPlace":"Berlin ; Heidelberg ; New York","dateIssuedDisp":"[May 2022]-","publisher":"Springer Medizin"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["ger"],"pubHistory":["Volume 28, Issue 5, (May 2022) -"],"part":{"extent":"5","text":"31(2025), Seite 1161-1165","volume":"31","pages":"1161-1165","year":"2025"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"Organ der Deutschen Krebsgesellschaft e.V.","title":"Die Onkologie","title_sort":"Onkologie"}],"id":{"zdb":["3120761-3"],"issn":["2731-7234"],"eki":["1805500619"]}}],"note":["Gesehen am 16.10.2025"],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"4 September 2025"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1938520122","language":["ger"],"person":[{"family":"Hofheinz","role":"aut","given":"Ralf-Dieter","display":"Hofheinz, Ralf-Dieter"},{"given":"Claus","role":"aut","family":"Rödel","display":"Rödel, Claus"},{"display":"Germer, Christoph-Thomas","given":"Christoph-Thomas","role":"aut","family":"Germer"}]} 
SRT |a HOFHEINZRAREKTUMKARZ4202